About Formation Bio
Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development.
Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others.
You can read more at the following links:
- Our Vision for AI in Pharma
- Our Current Drug Portfolio
- Our Technology & Platform
At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently.
About the Position
Formation Bio is seeking an Associate Director, Program Management - Asset Diligence & Integration to partner with our Business Development (BD) and cross-functional teams across the end-to-end asset diligence lifecycle—from initial screen through confirmatory diligence and integration. This role will lead late-stage diligence efforts, support asset onboarding post-acquisition, and help build scalable program management infrastructure that enhances execution, visibility, and governance.
Depending on portfolio needs, you may also flex into post-acquisition program management, driving near-term development milestones until steady-state ownership is established.
Key Responsibilities
Diligence Program Management
- Lead and manage the full diligence process from initial evaluation to pre-close.
- Coordinate cross-functional workstreams (Clinical, CMC, Regulatory, Nonclinical, QA, Commercial, Finance, Legal/IP).
- Maintain trackers, RAID logs, and timelines; deliver leadership updates and red-flag summaries.
- Orchestrate expert calls, debriefs, and management meetings, capturing insights and follow-ups.
Confirmatory Diligence Leadership
- Drive scientific, technical, and commercial deep dives across functions.
- Lead scenario planning for timelines, costs, and resources; partner with Finance to assess trade-offs and business impact.
Prepare executive-ready Go/No-Go materials outlining risks, mitigations, and term-sheet implications.
Program Management Infrastructure & Process Optimization
- Build and refine playbooks, templates, and decision-making frameworks for diligence and integration.
- Enhance Smartsheet-based dashboards, workflows, and reporting tools for portfolio governance.
- Identify and implement AI and automation tools to streamline workflows and accelerate decision-making.
- Drive cross-functional planning, risk management, and clear action tracking.
Flex Capacity (Post-Acquisition Support)
- Support early-stage execution for newly acquired assets, coordinating integrated development plans until long-term teams are established.
About You
- A builder who designs fit-for-purpose processes and scales operational excellence.
- Equally strong in strategic thinking and hands-on execution, with clear, concise communication at all levels.
- Thrive in high-growth, high-ambiguity environments and drive alignment and momentum.
- Curious about and eager to leverage AI and automation to improve PM efficiency and derive insights.
Qualifications
- Proven ability to integrate cross-functional inputs into actionable, business-driven plans.
- Strong stakeholder management and influencing skills in a matrixed organization.
- Proficiency with Smartsheet (certification or willingness to obtain) and advanced Excel/Google Sheets modeling.
- Experience in Inflammation & Immunology, CNS, Cardiovascular/Metabolic, or Dermatology preferred.
- Familiarity with term sheets, diligence workplans, asset integration, and regulatory/quality transitions a plus.
Formation Bio is prioritizing hiring in key hubs, primarily the New York City and Boston metro areas, with additional growth in the Research Triangle (NC) and San Francisco Bay Area. Please only apply if you reside in these locations or are willing to relocate.
Compensation:
The target salary range for this role is: $168,000 - $210,000.
Salary ranges are informed by a number of factors including geographic location. The range provided includes base salary only. In addition to base salary, we offer equity, comprehensive benefits, generous perks, hybrid flexibility, and more. If this range doesn't match your expectations, please still apply because we may have something else for you.
You will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
#LI-hybrid
Top Skills
Similar Jobs at Formation Bio
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories

